Our lead scientist transforms complex challenges into scalable solutions. With deep expertise in novel synthetic route design, he bridges fundamental chemistry and practical manufacturing, ensuring your vision becomes a viable, high-quality product.
Our dedicated oncology unit specializes in synthesizing highly potent, complex intermediates for targeted therapies and ADCs. We handle potent compounds with stringent containment, developing efficient routes for cytotoxic payloads, linkers, and other critical building blocks to accelerate your life-saving innovations.
This platform focuses on designing and synthesizing intermediates for CNS drug candidates. Our expertise includes crafting molecules with optimal lipophilicity, molecular weight, and polarity to enhance BBB penetration, supporting the development of novel treatments for neurological and psychiatric disorders.
We excel in the precise synthesis of chiral, conformationally restricted intermediates that mimic or modulate key neurotransmitters (e.g., GABA, glutamate, dopamine). Our capabilities enable the development of novel small molecules for neurological conditions, from epilepsy to neurodegenerative diseases.
Our custom services are built on a foundation of deep technical collaboration. We don't just follow a blueprint; we co-create the solution with you. From initial concept and route scouting to scalable process development and reliable cGMP supply, we integrate seamlessly into your project. Our expertise in advanced synthetic chemistry—including catalysis, organometallics, and cryogenics—enables us to navigate complex molecular challenges. We are committed to transforming your specific requirements into a robust, efficient, and high-quality supply chain, accelerating your timeline from discovery to delivery.
B608, #25 Shenbin Rd, Minhang District, Shanghai, China
English
